Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Dorocubicel by ExCellThera for Blood Cancer: Likelihood of Approval
Dorocubicel is under clinical development by ExCellThera and currently in Phase II for Blood Cancer. According to GlobalData, Phase II...
Data Insights
Dorocubicel by ExCellThera for Myelodysplastic Syndrome: Likelihood of Approval
Dorocubicel is under clinical development by ExCellThera and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase II...